Publikationen in Zusammenarbeit mit Forschern von Università di Perugia (8)

2022

  1. From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase

    European Journal of Medicinal Chemistry, Vol. 209

2019

  1. Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation

    European Journal of Medicinal Chemistry, Vol. 182

2018

  1. 2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors

    Chemical Biology and Drug Design, Vol. 86, Núm. 4, pp. 531-545